title: Risk of Allergic Conditions in Children Born to Women With Systemic Lupus Erythematosus.
abstract: Limited evidence suggests a potentially increased risk of allergic conditions in offspring born to women with systemic lupus erythematosus (SLE). In a large population-based study, we aimed to determine if children born to mothers with SLE have an increased risk of allergic conditions compared to children born to mothers without SLE.
  
  
  
  Using the Offspring of SLE Mothers Registry, we identified children born live to mothers with SLE and their matched controls, and ascertained the number of allergic conditions (asthma, allergic rhinitis, eczema, urticaria, angioedema, and anaphylaxis) based on ≥1 hospitalization or ≥1 or 2 physician(s) visit(s) with a relevant diagnostic code. We adjusted for maternal age, education, race/ethnicity, obstetrics complications, calendar year of birth, sex of the child, and maternal medication.
  
  
  
  There were 509 women with SLE who had 719 children, while 5,824 matched controls had 8,493 children. The mean ± SD followup period was 9.1 ± 5.8 years. Compared to controls, more children born to mothers with SLE had evidence of allergic conditions (43.9% [95% confidence interval (95% CI) 40.4-47.6] versus 38.1% [95% CI 37.0-39.1]). In multivariate analysis (n = 9,212), children born to mothers with SLE had an increased risk of allergic conditions versus control children (odds ratio 1.35 [95% CI 1.13-1.61]).
  
  
  
  Compared to children from the general population, children born to women with SLE may have an increased risk of allergic conditions. Genetics, shared environmental exposures, as well as in utero exposure to maternal autoantibodies and cytokines may mediate this increased risk.
authors.affiliation: McGill University Health Centre, Montreal, Quebec, Canada.
authors.forename: Julie
authors.initials: J
authors.lastname: Couture
authors.affiliation: McGill University Health Centre, Montreal, Quebec, Canada.
authors.forename: Moshe
authors.initials: M
authors.lastname: Ben-Shoshan
authors.affiliation: McGill University Health Centre, Montreal, Quebec, Canada.
authors.forename: Christian A
authors.initials: CA
authors.lastname: Pineau
authors.affiliation: McGill University Health Centre, Montreal, Quebec, Canada.
authors.forename: Susan
authors.initials: S
authors.lastname: Scott
authors.affiliation: University of Calgary, Calgary, Alberta, Canada.
authors.forename: Ann E
authors.initials: AE
authors.lastname: Clarke
authors.affiliation: McGill University Health Centre, Montreal, Quebec, Canada.
authors.forename: Sasha
authors.initials: S
authors.lastname: Bernatsky
authors.affiliation: McGill University Health Centre, Montreal, Quebec, Canada.
authors.forename: Evelyne
authors.initials: E
authors.lastname: Vinet
mesh_terms: D000293:Adolescent; D000328:Adult; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D008297:Male; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011792:Quebec; D012042:Registries; D018570:Risk Assessment; D012307:Risk Factors